Introduction {#S8}
============

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (Covid-19) and is an evolving pandemic. Limited data are available characterizing SARS-Cov-2 infection in the United States. Unadjusted analyses restricted to Covid-19 cases in China,^[@R1]--[@R5]^ Italy,^[@R6]^ and the United States^[@R7],[@R8]^ suggest that older age, diabetes, chronic obstructive lung disease (COPD), hypertension, vascular disease, renal disease, and liver disease are associated with more severe disease. Further, while some have speculated that use of angiotensin converting enzyme inhibitor (ACE), angiotensin II receptor blockers (ARB), and nonsteroidal anti-inflammatory drugs (NSAID) may exacerbate disease,^[@R9],[@R10]^ no analysis of this question has been published.

The Department of Veterans Affairs (VA) is the largest integrated healthcare system in the United States. All care is recorded in a national electronic health record with daily uploads into a central data repository. As a result, it is possible to extract data on patients tested for Covid-19, including outpatient and inpatient records, laboratory values, and pharmacy fill/refill data. When a well-characterized longitudinal cohort is supplemented with Covid-19 testing data, it is possible to answer important questions rapidly using validated methods.

The VA Birth Cohort includes all Veterans born between 1945 and 1965, over 2 million living individuals aged 54--75 years,^[@R11],[@R12]^ a demographic at particularly high risk of adverse outcomes from Covid-19.^[@R1]--[@R4]^ Using unadjusted and adjusted analyses, we consider a wide range of factors either associated with testing positive for Covid-19 and subsequent hospitalization and intensive care in the national VA system as of March 30, 2020.

Methods {#S9}
=======

Data Source {#S10}
-----------

Using data from the VA national Corporate Data Warehouse on members of the VA Birth Cohort, we identified patients tested for Covid-19 from date of first recorded VA test on February 8, 2020 through March 30, 2020. Available data included demographics, outpatient and inpatient encounters, diagnoses, laboratory results, vital signs, health factors (e.g., smoking and alcohol health behaviors), and pharmacy dispensing records.

VA Birth Cohort was approved by the Institutional Review Boards of VA Connecticut Healthcare System and Yale University. It has been granted a waiver of informed consent and is Health Insurance Portability and Accountability Act compliant.

Data Collection {#S11}
---------------

We selected previously validated cohort characteristics and those that have been evaluated in prior Covid-19 reports.^[@R1],[@R13]^ Baseline was defined as the date of specimen collection for the Covid-19 test unless testing occurred during hospitalization, in which case it was date of admission. Demographics included age at baseline, sex, race/ethnicity, and rural/urban residence. Residence was defined using geographic information system coding based upon established criteria.^[@R14]^

Main Study Outcomes {#S12}
-------------------

We examined three outcomes: 1) testing positive for SARS-CoV-2 (Covid-19+), 2) hospitalization, and 3) admission to an intensive care unit (ICU). We used VA inpatient bed section codes 12 (medical) and 13 (cardiac) to identify ICU admission.

Covid-19 tests {#S13}
--------------

We identified Covid-19 tests conducted in the VA using text searching of laboratory results containing terms consistent with SARS-CoV-2 or Covid-19. If a patient had more than one test and all were negative we selected first negative, otherwise we used date of first positive. Patients for whom results were pending (n=93) or inconclusive (n=33) were excluded. Nearly all tests utilized nasopharyngeal swabs, 1% were from other sources. Testing was performed in VA, state public health and commercial reference laboratories using emergency use authorization approved SARS-CoV-2 assays.

Comorbidity {#S14}
-----------

We extracted diagnostic codes for asthma, cancer, COPD, chronic kidney disease, diabetes mellitus, hypertension, liver disease, vascular disease, and alcohol use disorder (definitions provided in **eTable 1**). We used a validated algorithm to capture smoking status derived from health factors.^[@R15]^

Pharmacy Data {#S15}
-------------

We collected pharmacy fills for ACE/ARBs, chemotherapy and immunosuppressive drugs, and prescription NSAIDs and determined which medications were active in the year prior to testing. Exposure windows for NSAIDS ended 14 days prior to baseline to minimize the potential of protopathic bias. Exposure windows for other medications not used to treat Covid-19 symptoms ended three days prior to baseline.

Vital Signs, Clinical Laboratory Data, and a Summary Measure of Physiologic Injury {#S16}
----------------------------------------------------------------------------------

Vital signs measured within two days of baseline included body mass index (BMI), oxygen saturation, pulse, systolic blood pressure, and temperature. We chose laboratory findings closest to baseline within a year prior or up to one week after baseline. Measures included alanine aminotransferase, albumin, aspartate aminotransferase, creatinine, estimated glomerular filtration rate,^[@R16]^ fibrosis-4 score (FIB-4),^[@R17]^ hemoglobin, platelet count, total white blood cell count, and lymphocyte count. We calculated a validated composite measure of physiologic injury (VACS Index) which includes age, BMI, and all previously mentioned laboratory measures save lymphocyte count^[@R18],[@R19]^ (details in **eMethods**).

Statistical Analysis {#S17}
--------------------

We evaluated characteristics of patients undergoing Covid-19 testing, and among Covid-19+, factors associated with hospital admission and intensive care, using chi-square, Fisher's exact, and Wilcoxon rank-sum tests, as appropriate. For bivariate comparisons, statistical significance reflects complete case analysis. When modeling Covid-19+, we restricted analyses to factors available when initially evaluating a patient (i.e., demographic data, comorbid conditions, medication history, health behaviors, and vital signs). Because age, black race, ACE/ARB use, and NSAID use are of special interest, we included them in all multivariable models. Otherwise, variables significant at p\<0.05 in unadjusted analyses were included in the multivariable models. When modeling hospital admission and intensive care, we compared C-statistics for models including individual laboratory values to a model including VACS Index. In *post hoc* analyses we explored the association between black race and Covid-19+ with a multivariable model conditioned on site, among sites having at least five positive tests.

We report missing data for each variable. We used multiple imputation to impute missing laboratory measures, vital signs, and smoking status. The imputation model included outcomes and all covariates. Estimates from regressions performed on 10 imputed data sets were combined using Rubin's rules.^[@R20]^ Analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and Stata version 14.2 (StataCorp, LLC., College Station, TX). We used R version 3.6.3 to map Covid-19 cases in the VA system overall and those captured in the VA Birth Cohort.

Results {#S18}
=======

In the year prior to the Covid-19 outbreak, the VA Birth Cohort included 2,026,277 living individuals: 1,866,256 (92.1%) men and 159,971 (7.9%) women. The cohort includes 1,369,454 (67.6%) white, 402,295 (19.9%) black, 106,639 (5.3%) Latinx, and 147,839 (7.3%) other or unknown race/ethnicity. More than a third of the subjects (745,284 or 36.8%) were 70--75 years of age, 23.3% (n=472,732) were 65--69 years old, 20.1% (n=407,900) were 60--64 years old, and 19.8% (n=400,311) were 54--59 years old. Of these, 3,789 individuals have been tested for Covid-19 (18.7 per 10,000 persons) since February 8, 2020 through March 30, 2020.

Testing per 10,000 persons varied by race, sex, age, and residence (p\<0.001 for all). Black Veterans were more likely to be tested than white Veterans (28.0 versus 15.6). Women were more likely to be tested than men (23.3 versus 18.3). Testing generally decreased with age (age 54--59: 21.5; age 60--64: 22.2; age 65--69:18.6; and age 70--75:15.4). Veterans living in urban settings were more likely to be tested than those in rural settings (39.2 vs. 5.8).

Among those tested, median age was 65.7 years ([Table 1](#T1){ref-type="table"}), 90.2% were male, 29.7% were black, and 81.1% lived in urban settings. Common comorbid conditions were hypertension (65.0%), diabetes mellitus (37.8%), vascular disease (28.9%), COPD (26.2%), and alcohol use disorder (13.9%). Receipt of ACE/ARBs (40.5%) or NSAIDs (30.5%) was common. Among those tested, 42.3% were current smokers, 40.8% were obese (BMI \>30 kg/m^2^), 7.7% were febrile (\>100.4°F), 13.1% were hypoxic (oxygen saturation \<93%), and 35.4% were tachycardic (pulse \>90 beats per minute).

Testing Positive vs. Negative for Covid-19 {#S19}
------------------------------------------

Of the 3,789 patients tested in the VA Birth Cohort, 585 (15.4%, 95% Cl 14.3--16.6) were Covid-19+, representing approximately half (585/1244, 47%) of all Covid-19+ patients in the VA as of March 30, 2020 ([Figure 1a](#F1){ref-type="fig"} and **eFigure 1**). In unadjusted analyses, factors associated with Covid-19+ ([Table 1](#T1){ref-type="table"}) included male sex, black race, urban residence, chronic kidney disease, diabetes, and hypertension (all p\<0.003). Smoking, COPD, and alcohol use disorder were associated with a lower probability of a positive test (all p\<0.001). No medication exposure was associated with a positive test. Vital signs associated with Covid-19+ included higher BMI, tachycardia, and higher temperature (all p\<0.001). All laboratory values were associated with Covid-19+ (all p\<0.001). Composite variables, eGFR and FIB-4, were also strongly associated (both p\<0.001).

In multivariable analyses ([Table 2](#T2){ref-type="table"}, C-statistic=0.806), black race (OR 4.68,8 95% Cl 3.79--5.78), male sex (OR 3.17, 95% Cl 2.03--4.94), urban residence (OR 1.60, 95% Cl 1.17--2.20), higher temperature (OR 1.70, 95% Cl 1.58--1.84 per 1°F), lower systolic blood pressure (OR 1.44, 95% Cl 1.16--1.78), and prior use of NSAIDS (OR 1.27, 95% Cl 1.02--1.58) were associated with increased likelihood of Covid-19+. Current smoking (OR 0.45, 95% Cl 0.35--0.57), alcohol use disorder (OR 0.58, 95% Cl 0.41--0.83), and COPD (OR 0.67, 95%CI 0.50--0.88) were associated with decreased likelihood of Covid-19+. Results were similar in complete case analysis (**eTable 2**).

In *post hoc* analyses, we observed that black Veterans were more likely to be tested at sites with higher Covid-19 prevalence ([Figure 1b](#F1){ref-type="fig"}). A model conditional on site ([Table 2](#T2){ref-type="table"}) reduced the association with black race (OR 2.56, 95% Cl 1.89--3.46) and increased the association with male sex (OR 3.85, 95% Cl 2.20--6.74). Associations with other factors were consistent with unconditional estimates.

Risk Factors for Hospitalization and Intensive Care {#S20}
---------------------------------------------------

Among 585 Covid-19+ patients, 297 (50.8%, 95% Cl 46.6--54.9%) were hospitalized and 122 (20.9%, 95% Cl 17.6--24.4%) received intensive care. In bivariate analyses, age, chronic kidney disease, COPD, diabetes, hypertension, vascular disease, ACE/ARB exposure, and decreased oxygen saturation, and elevated temperature were associated with hospitalization and intensive care (all p\<0.05, [Table 3a](#T3){ref-type="table"} and [Table 3b](#T4){ref-type="table"}). All laboratory abnormalities investigated were associated with hospitalization and intensive care (all p\<0.05). Median VACS Index scores varied substantially between those hospitalized versus not hospitalized (78.7 vs. 66.2, p\<0.001) and between those receiving and not receiving intensive care (82.0 vs. 69.4, p\<0.001).

Parallel models, first adjusted for all significant factors identified in bivariate analyses and then substituting VACS Index for all laboratory tests, demonstrated good discrimination for hospitalization ([Table 4](#T5){ref-type="table"}, C-statistics: 0.859, 0.834) and intensive care (C-statistics: 0.876, 0.835). White blood cell count, lymphocyte count, eGFR, albumin and FIB-4 were all independently associated with hospitalization and intensive care ([Table 4](#T5){ref-type="table"}). The most pronounced association was for patients with FIB-4\>3.25 -- adjusted OR 8.73 (95% Cl 4.11--18.56) for hospitalization and 8.40 (95% Cl 2.90--24.28) for intensive care -- compared to those with FIB-4\<1.45. Of note, associations were stronger for FIB-4 and eGFR than for components of these measures (data not otherwise shown).

While COPD, diabetes, hypertension, kidney disease, vascular disease and exposure to ACE/ARB exposure were associated with hospitalization and intensive care in unadjusted analyses, they were not significantly associated after adjusting for laboratory abnormalities and vital signs ([Table 4](#T5){ref-type="table"}). Results were similar in complete case analysis (**eTable 3**).

Discussion {#S21}
==========

Our analysis represents over 2 million veterans, aged 54--75 years, receiving care in the largest integrated healthcare system in the United States. The study was conducted within an established cohort and based on well annotated national electronic health record data, enabling a rapid and reliable analysis of Covid-19 testing and initial outcomes. As a result, we were able to validate and extend previous findings, to include a careful consideration of who is Covid-19+ and, given a positive test, what factors were independently associated with hospitalization and intensive care. We found that black Veterans were twice as likely to be tested and 2.5 times as likely to test positive than non-black Veterans, even after adjusting for urban residence and conditioning on geographic location. While we saw modest evidence of an association between exposure to NSAIDs and risk of Covid-19+, vital signs and laboratory measures better characterized risk of hospitalization and intensive care than did comorbid diagnoses or prior medication exposures.

In unadjusted analyses, black Veterans were over four times as likely to test positive compared to non-black Veterans; adjusting for urban versus rural residence did not change this association. While black Veterans were much more likely to be tested at high prevalence facilities, conditioning our analysis by site did not eliminate the association; black race retained over a two-fold increased risk for testing Covid-19+. Of note, black Veterans were also more likely to be tested, which could dilute the proportion positive. Further, black Veterans did not experience higher rates of hospitalization or intensive care. Based on prior experience with 1918 Spanish Flu and 2009 H1N1 epidemic, public health experts have warned that minority populations may be at higher risk of infection due to reduced capacity to implement physical distancing.^[@R21],[@R22]^ Our findings may be an underestimate of the US population as racial health disparities in VA tend to be smaller than in the private sector.^[@R23]^

Women were more likely to be tested for Covid-19 than men, and men were twice as likely to test positive. This association strengthened after adjustment and in conditional analyses ([Table 2](#T2){ref-type="table"}) but should be considered preliminary given limited numbers of women in this analysis.

As reported previously^[@R24]^ elevated temperature was independently associated with testing positive, hospital admission and intensive care, underscoring the value of including fever in the current testing algorithms. Findings from the multivariable regression suggest that other factors might also be used to indicate a test, including black race, male sex, and lack of an alternative explanation for cough symptoms. To wit, we found that current smoking, COPD, and alcohol use disorder, factors that generally increase risk of pneumonia, were associated with decreased probability of testing positive. While they were not associated with hospitalization or intensive care, it is too early to tell if these factors are associated with subsequent outcomes such as respiratory failure or mortality.

Presence of particular comorbid diagnoses may be less prognostic than overall acute on chronic injury reflected in laboratory abnormalities largely encompassed in the VACS Index. In unadjusted analyses, several comorbid conditions were associated with hospitalization and intensive care but were not independently associated after adjusting for vital signs and laboratory data. Further, while elevated white blood cell counts and decreased lymphocyte counts were associated with hospitalization and intensive care, the pronounced independent association with FIB-4 (a composite of platelets and transaminases) and albumin suggest that virally induced hepatic inflammation may be a harbinger of the cytokine storm.^[@R25]--[@R27]^

VACS Index, which includes FIB-4, albumin, and white blood cell count, is predictive of mortality in many clinical settings.^[@R18]^ A five-point difference in score corresponds to a 30% difference in mortality. The 12.5-point difference in medians between the Veterans who were and were not admitted, and the 12.6-point difference between those who received and did not receive intensive care underscores the wide range of prognoses seen with Covid-19. Future work will need to determine whether VACS Index might be used in medical triage of Covid-19+ patients.

Our analysis is one of the first to address concerns regarding exposure to NSAIDS and ACE/ARBs and Covid-19.^[@R9],[@R10]^ We found NSAID exposure was modestly associated with Covid-19+ in unadjusted and adjusted analyses, but not with hospitalization or intensive care. Among those testing positive, ACE/ARB exposure was associated with hospitalization and intensive care in unadjusted analyses, but associations lost statistical significance with hospitalization and diminished with intensive care after adjusting for clinical measures, including hypertension and blood pressure. However, confidence intervals were wide, include clinically important differences, and conclusions may change as the epidemic evolves. We will continue to update these analyses as more data become available.

While this analysis adds information to the evolving pandemic, its limitations must be kept in mind. First, a small proportion of Veterans have been tested and rates of testing vary widely by site. Second, women represented a small number of Veterans in the sample (184 tested, 13 positive). Third, our analysis of outcomes is preliminary as many Covid-19+ patients are still in care. Fourth, while a strength of this analysis is our ability to determine active VA medications, we could only detect NSAID exposure based upon VA pharmacy fill/refill data, individuals are also likely to purchase NSAIDS over the counter. As real-world data become available, more sophisticated and focused pharmacoepidemiological analyses will be required to address concerns regarding potential risk of medications associated with Covid-19.

Conclusion {#S22}
==========

Black race was strongly associated with Covid-19+, but not with hospitalization or intensive care. Unadjusted associations between medication exposure, comorbid disease, and hospitalization and intensive care are diminished after adjustment. Risk of hospitalization and intensive care associated with Covid-19 may be better characterized by vital signs and measures of physiologic injury than by comorbid conditions or medication history.
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###### 

Characteristics of patients tested for Covid-19 among all patients aged 54--75 years in the Veterans Health Administration as of March 30, 2020

                                                                                                                                     Covid-19 test result                                        
  -------------------------------------------------------------------------------- ------------------- --------- ------------------- ---------------------- --------- ------ --------- --------- -------------------
  Sample size, n                                                                   3789                (100.0)                       585                    (100.0)   3204   (100.0)             15.4 (14.3--16.6)
  **Demographics**                                                                                                                                                                               
  Age, years                                                                                                                                                                                     
   Median (IQR)                                                                    65.7 (60.5--70.7)   0         66.1 (60.4--71.0)   65.6 (60.5--70.7)      0.24                                 
   54--59                                                                          861                 (22.7)                        135                    (23.1)    726    (22.7)    0.21      15.7 (13.3--18.3)
   60--64                                                                          906                 (23.9)                        135                    (23.1)    771    (24.1)              14.9 (12.6--17.4)
   65--69                                                                          877                 (23.1)                        120                    (20.5)    757    (23.6)              13.7 (11.5--16.1)
   70--75                                                                          1145                (30.2)                        195                    (33.3)    950    (29.7)              17.0 (14.9--19.3)
  Sex                                                                                                                                                                                            
   Female                                                                          372                 (9.8)     0                   27                     (4.6)     345    (10.8)    \<0.001   7.3 (4.8--10.4)
   Male                                                                            3417                (90.2)                        558                    (95.4)    2859   (89.2)              16.3 (15.1--17.6)
  Race/ethnicity                                                                                                                                                                                 
   White                                                                           2135                (56.3)    0                   161                    (27.5)    1974   (61.6)    \<0.001   7.5 (6.5--8.7)
   Black                                                                           1126                (29.7)                        350                    (59.8)    776    (24.2)              31.1 (28.4--33.9)
   Latinx                                                                          294                 (7.8)                         48                     (8.2)     246    (7.7)               16.3 (12.3--21.1)
   Other/unknown                                                                   234                 (6.2)                         26                     (4.4)     208    (6.5)               11.1 (7.4--15.9)
  Residence type                                                                                                                                                                                 
   Rural                                                                           718                 (18.9)    0                   56                     (9.6)     662    (20.7)    \<0.001   7.8 (6.0--10.0)
   Urban                                                                           3071                (81.1)                        529                    (90.4)    2542   (79.3)              17.2 (15.9--18.6)
  **Baseline comorbidity**                                                                                                                                                                       
  Asthma                                                                                                                                                                                         
   No                                                                              3506                (92.5)    0                   540                    (92.3)    2966   (92.6)    0.80      15.4 (14.2--16.6)
   Yes                                                                             283                 (7.5)                         45                     (7.7)     238    (7.4)               15.9 (11.8--20.7)
  Cancer                                                                                                                                                                                         
   No                                                                              3218                (84.9)    0                   502                    (85.8)    2716   (84.8)    0.57      15.6 (14.4--16.9)
   Yes                                                                             571                 (15.1)                        83                     (14.2)    488    (15.2)              14.5 (11.8--17.7)
  Chronic kidney disease                                                                                                                                                                         
   No                                                                              3228                (85.2)    0                   474                    (81.0)    2754   (86.0)    0.003     14.7 (13.5--16.0)
   Yes                                                                             561                 (14.8)                        111                    (19.0)    450    (14.0)              19.8 (16.6--23.3)
  Chronic obstructive pulmonary disease                                                                                                                                                          
   No                                                                              2796                (73.8)    0                   495                    (84.6)    2301   (71.8)    \<0.001   17.7 (16.3--19.2)
   Yes                                                                             993                 (26.2)                        90                     (15.4)    903    (28.2)              9.1 (7.4--11.0)
  Diabetes mellitus                                                                                                                                                                              
   No                                                                              2358                (62.2)    0                   325                    (55.6)    2033   (63.5)    \<0.001   13.8 (12.4--15.2)
   Yes                                                                             1431                (37.8)                        260                    (44.4)    1171   (36.5)              18.2 (16.2--20.3)
  Hypertension                                                                                                                                                                                   
   No                                                                              1326                (35.0)    0                   162                    (27.7)    1164   (36.3)    \<0.001   12.2 (10.5--14.1)
   Yes                                                                             2463                (65.0)                        423                    (72.3)    2040   (63.7)              17.2 (15.7--18.7)
  Liver disease                                                                                                                                                                                  
   No                                                                              3323                (87.7)    0                   525                    (89.7)    2798   (87.3)    0.12      15.8 (14.6--17.1)
   Yes                                                                             466                 (12.3)                        60                     (10.3)    406    (12.7)              12.9 (10--16.3)
  Vascular disease                                                                                                                                                                               
   No                                                                              2694                (71.1)    0                   422                    (72.1)    2272   (70.9)    0.59      15.7 (14.3--17.1)
   Yes                                                                             1095                (28.9)                        163                    (27.9)    932    (29.1)              14.9 (12.8--17.1)
  **Substance use**                                                                                                                                                                              
  Alcohol use disorder                                                                                                                                                                           
   No                                                                              3261                (86.1)    0                   537                    (91.8)    2724   (85.0)    \<0.001   16.5 (15.2--17.8)
   Yes                                                                             528                 (13.9)                        48                     (8.2)     480    (15.0)              9.1 (6.8--11.9)
  Smoking                                                                                                                                                                                        
   Never                                                                           1042                (27.5)    261                 216                    (36.9)    826    (25.8)    \<0.001   20.7 (18.3--23.3)
   Former                                                                          883                 (23.3)                        179                    (30.6)    704    (22.0)              20.3 (17.7--23.1)
   Current                                                                         1603                (42.3)                        159                    (27.2)    1444   (45.1)              9.9 (8.5--11.5)
  **Medication history in year prior to test date**                                                                                                                                              
  Any angiotensin converting enzyme inhibitor or angiotensin II receptor blocker                                                                                                                 
   No                                                                              2257                (59.6)    0                   330                    (56.4)    1927   (60.1)    0.10      14.6 (13.2--16.2)
   Yes                                                                             1532                (40.4)                        255                    (43.6)    1277   (39.9)              16.6 (14.8--18.6)
  Angiotensin converting enzyme inhibitor                                                                                                                                                        
   No                                                                              2778                (73.3)    0                   416                    (71.1)    2362   (73.7)    0.20      15.0 (13.7--16.4)
   Yes                                                                             1011                (26.7)                        169                    (28.9)    842    (26.3)              16.7 (14.5--19.2)
  Angiotensin II receptor blocker                                                                                                                                                                
   No                                                                              3226                (85.1)    0                   491                    (83.9)    2735   (85.4)    0.38      15.2 (14.0--16.5)
   Yes                                                                             563                 (14.9)                        94                     (16.1)    469    (14.6)              16.7 (13.7--20.0)
  Chemotherapy or immunsuppresive drug                                                                                                                                                           
   No                                                                              3568                (94.2)    0                   556                    (95.0)    3012   (94.0)    0.39      15.6 (14.4--16.8)
   Yes                                                                             221                 (5.8)                         29                     (5.0)     192    (6.0)               13.1 (9.0--18.3)
  Nonsteroidal anti-inflammatory drug, (−365, −14 days)                                                                                                                                          
   No                                                                              2634                (69.5)    0                   392                    (67.0)    2242   (70.0)    0.16      14.9 (13.5--16.3)
   Yes                                                                             1155                (30.5)                        193                    (33.0)    962    (30.0)              16.7 (14.6--19.0)
  **Vital signs at test date**                                                                                                                                                                   
  Body mass index, kg/m^2^                                                                                                                                                                       
   \<25.0                                                                          779                 (20.6)    393                 73                     (12.5)    706    (22.0)    \<0.001   9.4 (7.4--11.6)
   25.0--29.9                                                                      1070                (28.2)                        166                    (28.4)    904    (28.2)              15.5 (13.4--17.8)
   ≥30                                                                             1547                (40.8)                        291                    (49.7)    1256   (39.2)              18.8 (16.9--20.9)
  Hypoxia (oxygen saturation ≤93%)                                                                                                                                                               
   No                                                                              2433                (64.2)    860                 443                    (75.7)    1990   (62.1)    0.20      18.2 (16.7--19.8)
   Yes                                                                             496                 (13.1)                        78                     (13.3)    418    (13.0)              15.7 (12.6--19.2)
  Pulse ≥90 beats per minute                                                                                                                                                                     
   No                                                                              2033                (53.7)    416                 295                    (50.4)    1738   (54.2)    \<0.001   14.5 (13.0--16.1)
   Yes                                                                             1340                (35.4)                        257                    (43.9)    1083   (33.8)              19.2 (17.1--21.4)
  Systolic blood pressure, mm Hg                                                                                                                                                                 
   \<90                                                                            355                 (9.4)     448                 63                     (10.8)    292    (9.1)     0.11      17.8 (13.9--22.1)
   90--140                                                                         1565                (41.3)                        274                    (46.8)    1291   (40.3)              17.5 (15.7--19.5)
   ≥140                                                                            1421                (37.5)                        211                    (36.1)    1210   (37.8)              14.9 (13.0--16.8)
  Temperature, °F                                                                                                                                                                                
   ≤98.6                                                                           2142                (56.5)    405                 204                    (34.9)    1938   (60.5)    \<0.001   9.5 (8.3--10.9)
   98.7--100.3                                                                     953                 (25.2)                        227                    (38.8)    726    (22.7)              23.8 (21.2--26.7)
   ≥100.4                                                                          289                 (7.6)                         120                    (20.5)    169    (5.3)               41.5 (35.8--47.4)
  **Laboratory findings at test date**                                                                                                                                                           
  Alanine aminotransferase, U/L                                                                                                                                                                  
   Median (IQR)                                                                    23.0 (16.0--34.0)   400       28.0 (19.0--41.0)   22.0 (16.0--33.0)      \<0.001                              
   ≤40                                                                             2829                (74.7)                        406                    (69.4)    2423   (75.6)    \<0.001   14.4 (13.1--15.7)
   \>40                                                                            560                 (14.8)                        138                    (23.6)    422    (13.2)              24.6 (21.1--28.4)
  Albumin, g/dL                                                                                                                                                                                  
   Median (IQR)                                                                    3.9 (3.5--4.2)      383       3.8 (3.5--4.2)      3.9 (3.5--4.2)         0.78                                 
   ≥3.5                                                                            2596                (68.5)                        415                    (70.9)    2181   (68.1)    1.00      16.0 (14.6--17.5)
   \<3.5                                                                           810                 (21.4)                        129                    (22.1)    681    (21.3)              15.9 (13.5--18.6)
  Aspartate aminotransferase, U/L                                                                                                                                                                
   Median (IQR)                                                                    23.0(18.0--32.0)    356       29.0(21.5--43.0)    22.0(17.0--30.0)       \<0.001                              
   ≤40                                                                             2902                (76.6)                        391                    (66.8)    2511   (78.4)    \<0.001   13.5 (12.3--14.8)
   \>40                                                                            531                 (14.0)                        157                    (26.8)    374    (11.7)              29.6 (25.7--33.7)
  Creatinine, mg/dL                                                                                                                                                                              
   Median (IQR)                                                                    1.1 (0.9--1.3)      186       1.1 (1.0--1.5)      1.0 (0.9--1.3)         \<0.001                              
   ≤1.5                                                                            3033                (80.0)                        435                    (74.4)    2598   (81.1)    \<0.001   14.3 (13.1--15.6)
   \>1.5                                                                           570                 (15.0)                        130                    (22.2)    440    (13.7)              22.8 (19.4--26.5)
  eGFR, mL/min                                                                                                                                                                                   
   Median (IQR)                                                                    75.0 (59.0--91.0)   168       71.5 (53.0--87.0)   76.0 (60.0--92.0)      \<0.001                              
   ≥15                                                                             3492                (92.2)                        541                    (92.5)    2951   (92.1)    0.11      15.5 (14.3--16.7)
   \<15                                                                            129                 (3.4)                         27                     (4.6)     102    (3.2)               20.9 (14.3--29.0)
  FIB-4                                                                                                                                                                                          
   \<1.45                                                                          1499                (39.6)    628                 139                    (23.8)    1360   (42.4)    \<0.001   9.3 (7.9--10.9)
   1.45--3.25                                                                      1266                (33.4)                        263                    (45.0)    1003   (31.3)              20.8 (18.6--23.1)
   \>3.25                                                                          396                 (10.5)                        114                    (19.5)    282    (8.8)               28.8 (24.4--33.5)
  Hemoglobin, g/dL                                                                                                                                                                               
   Median (IQR)                                                                    13.8 (12.2--15.0)   445       13.9 (12.6--14.9)   13.8 (12.2--15.0)      0.09                                 
   ≥10                                                                             3097                (81.7)                        523                    (89.4)    2574   (80.3)    \<0.001   16.9 (15.6--18.3)
   \<10                                                                            247                 (6.5)                         17                     (2.9)     230    (7.2)               6.9 (4.1--10.8)
  Platelet count, K/μL                                                                                                                                                                           
   Median (IQR)                                                                    218 (173--267)      423       193 (154--230)      223 (178--275)         \<0.001                              
   ≥150                                                                            2875                (75.9)                        416                    (71.1)    2459   (76.7)    \<0.001   14.5 (13.2--15.8)
   \<150                                                                           491                 (13.0)                        121                    (20.7)    370    (11.5)              24.6 (20.9--28.7)
  White blood cell count, K/μL                                                                                                                                                                   
   Median (IQR)                                                                    7.5 (5.7--10.0)     288       5.9 (4.7--7.5)      7.8 (6.0--10.4)        \<0.001                              
   \<4                                                                             191                 (5.0)                         72                     (12.3)    119    (3.7)     \<0.001   37.7 (30.8--45.0)
   4--9.9                                                                          2448                (64.6)                        432                    (73.8)    2016   (62.9)              17.7 (16.2--19.2)
   ≥10                                                                             862                 (22.8)                        49                     (8.4)     813    (25.4)              5.7 (4.2--7.5)
  Lymphocyte count, K/μL Median (IQR)                                              1.4 (1.0--2.0)      628       1.1 (0.8--1.6)      1.5 (1.0--2.1)         \<0.001                              
   ≥0.8                                                                            2626                (69.3)                        363                    (62.1)    2263   (70.6)    \<0.001   13.8 (12.5--15.2)
   \<0.8                                                                           535                 (14.1)                        130                    (22.2)    405    (12.6)              24.3 (20.7--28.2)
  **Clinical outcomes**                                                                                                                                                                          
  Hospitalized                                                                                                                                                                                   
   No                                                                              2277                (60.1)    0                   288                    (49.2)    1989   (62.1)    \<0.001   12.7 (11.3--14.1)
   Yes                                                                             1512                (39.9)                        297                    (50.8)    1215   (37.9)              19.6 (17.7--21.7)
  Intensive care unit admission                                                                                                                                                                  
   No                                                                              3381                (89.2)    0                   463                    (79.1)    2918   (91.1)    \<0.001   13.7 (12.6--14.9)
   Yes                                                                             408                 (10.8)                        122                    (20.9)    286    (8.9)               29.9 (25.5--34.6)
  Death during hospitalization                                                                                                                                                                   
   No                                                                              3744                (98.8)    0                   568                    (97.1)    3176   (99.1)    \<0.001   15.2 (14.0--16.4)
   Yes                                                                             45                  (1.2)                         17                     (2.9)     28     (0.9)               37.8 (23.8--53.5)

Abbreviations: Covid-19, coronavirus disease 2019; IQR, interquartile range; eGFR, estimated glomerular filtration rate, FIB-4, fibrosis 4 score

P-values calculated on non-missing data

###### 

Crude and adjusted associations with testing positive for Covid-19 as of March 30, 2020

                                                                                           Positive Covid-19 test (n=585/3789)                       
  ---------------------------------------------------------------------------------------- ------------------------------------- ------------------- -------------------
  **Model details**                                                                                                                                  
  *C*-statistic                                                                            \-                                    0.806               n/a
  **Demographics**                                                                                                                                   
  Age, per 5-year increase                                                                 1.04 (0.97--1.12)                     1.05 (0.96--1.15)   1.02 (0.91--1.15)
  Sex, male vs. female                                                                     2.49 (1.67--3.73)                     3.17 (2.03--4.94)   3.85 (2.20--6.74)
  Race/ethnicity, black vs. other                                                          4.66 (3.88--5.60)                     4.68 (3.79--5.78)   2.56 (1.89--3.46)
  Residence type, urban vs. rural                                                          2.46 (1.84--3.28)                     1.60 (1.17--2.20)   1.04 (0.64--1.68)
  **Baseline comorbidity**                                                                                                                           
  Chronic kidney disease, yes vs. no                                                       1.43 (1.14--1.80)                     1.00 (0.76--1.33)   0.92 (0.64--1.31)
  Chronic obstructive pulmonary disease, yes vs. no                                        0.46 (0.37--0.59)                     0.67 (0.50--0.88)   0.77 (0.54--1.09)
  Diabetes mellitus, yes vs. no                                                            1.39 (1.16--1.66)                     1.01 (0.80--1.26)   0.89 (0.67--1.19)
  Hypertension, yes vs.no                                                                  1.49 (1.23--1.81)                     1.23 (0.95--1.60)   1.40 (1.00--1.96)
  **Substance use**                                                                                                                                  
  Alcohol use disorder, yes vs. no                                                         0.51 (0.37--0.69)                     0.58 (0.41--0.83)   0.52 (0.34--0.82)
  Current smoking, yes vs. no                                                              0.43 (0.35--0.52)                     0.45 (0.35--0.57)   0.45 (0.34--0.61)
  **Medication history in year prior to test date**                                                                                                  
  Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, yes vs. no   1.17 (0.98--1.39)                     0.98 (0.78--1.23)   0.93 (0.69--1.24)
  Nonsteroidal anti-inflammatory drug, yes vs. no                                          1.15 (0.95--1.39)                     1.27 (1.02--1.58)   1.16 (0.87--1.54)
  **Vital signs**                                                                                                                                    
  Systolic blood pressure, \<140 vs. ≥140 mm Hg                                            1.25 (1.03--1.51)                     1.44 (1.16--1.78)   1.29 (0.99--1.69)
  Body mass index, per 5 kg/m^2^ increase                                                  1.15 (1.08--1.23)                     1.09 (1.00--1.18)   1.10 (0.99--1.22)
  Oxygen saturation, ≤93% vs \>93%                                                         0.88 (0.68--1.15)                     1.04 (0.76--1.42)   1.04 (0.67--1.61)
  Pulse, per 5-beats per minute increase                                                   0.99 (0.99--1.00)                     0.99 (0.99--1.00)   1.00 (0.99--1.00)
  Temperature, per 1°F increase                                                            1.74 (1.62--1.87)                     1.70 (1.58--1.84)   1.69 (1.53--1.88)

Abbreviations: Covid-19, coronavirus disease 2019; OR, odds ratio; CI, confidence interval

Modeling stations with five or more Covid-19 cases and conditioning on station

###### 

Associations with hospitalization among Covid-19 cases aged 54--75 years in the Veterans Health Administration as of March 30, 2020

                                                                                                                                     Hospitalization                                         
  -------------------------------------------------------------------------------- ------------------- --------- ------------------- ------------------- --------- ----- --------- --------- -------------------
  n                                                                                585                 \(100\)                       297                 (100.0)   288   (100.0)             50.8 (46.6--54.9)
  **Demographics**                                                                                                                                                                           
  Age, years                                                                                                                                                                                 
   Median (IQR)                                                                    66.1 (60.4--71.0)   0         67.6 (61.7--71.6)   64.5 (59.7--70.5)   0.001                               
   54--59                                                                          135                 (23.1)                        58                  (19.5)    77    (26.7)    0.02      43.0 (34.5--51.8)
   60--64                                                                          135                 (23.1)                        62                  (20.9)    73    (25.3)              45.9 (37.3--54.7)
   65--69                                                                          120                 (20.5)                        62                  (20.9)    58    (20.1)              51.7 (42.4--60.9)
   70--75                                                                          195                 (33.3)                        115                 (38.7)    80    (27.8)              59.0 (51.7--66.0)
  Sex                                                                                                                                                                                        
   Female                                                                          27                  (4.6)     0                   8                   (2.7)     19    (6.6)     0.03      29.6 (13.8--50.2)
   Male                                                                            558                 (95.4)                        289                 (97.3)    269   (93.4)              51.8 (47.6--56.0)
  Race/ethnicity                                                                                                                                                                             
   White                                                                           161                 (27.5)    0                   79                  (26.6)    82    (28.5)    0.32      49.1 (41.1--57.1)
   Black                                                                           350                 (59.8)                        187                 (63.0)    163   (56.6)              53.4 (48.1--58.8)
   Latinx                                                                          48                  (8.2)                         20                  (6.7)     28    (9.7)               41.7 (27.6--56.8)
   Other/unknown                                                                   26                  (4.4)                         11                  (3.7)     15    (5.2)               42.3 (23.4--63.1)
  Residence type                                                                                                                                                                             
   Rural                                                                           56                  (9.6)     0                   27                  (9.1)     29    (10.1)    0.78      48.2 (34.7--62.0)
   Urban                                                                           529                 (90.4)                        270                 (90.9)    259   (89.9)              51.0 (46.7--55.4)
  **Baseline comorbidity**                                                                                                                                                                   
  Asthma                                                                                                                                                                                     
   No                                                                              540                 (92.3)    0                   273                 (91.9)    267   (92.7)    0.76      50.6 (46.3--54.9)
   Yes                                                                             45                  (7.7)                         24                  (8.1)     21    (7.3)               53.3 (37.9--68.3)
  Cancer                                                                                                                                                                                     
   No                                                                              502                 (85.8)    0                   252                 (84.8)    250   (86.8)    0.55      50.2 (45.7--54.7)
   Yes                                                                             83                  (14.2)                        45                  (15.2)    38    (13.2)              54.2 (42.9--65.2)
  Chronic kidney disease                                                                                                                                                                     
   No                                                                              474                 (81.0)    0                   222                 (74.7)    252   (87.5)    \<0.001   46.8 (42.3--51.4)
   Yes                                                                             111                 (19.0)                        75                  (25.3)    36    (12.5)              67.6 (58.0--76.2)
  Chronic obstructive pulmonary disease                                                                                                                                                      
   No                                                                              495                 (84.6)    0                   236                 (79.5)    259   (89.9)    \<0.001   47.7 (43.2--52.2)
   Yes                                                                             90                  (15.4)                        61                  (20.5)    29    (10.1)              67.8 (57.1--77.3)
  Diabetes mellitus                                                                                                                                                                          
   No                                                                              325                 (55.6)    0                   141                 (47.5)    184   (63.9)    \<0.001   43.4 (37.9--49.0)
   Yes                                                                             260                 (44.4)                        156                 (52.5)    104   (36.1)              60.0 (53.8--66.0)
  Hypertension                                                                                                                                                                               
   No                                                                              162                 (27.7)    0                   59                  (19.9)    103   (35.8)    \<0.001   36.4 (29.0--44.3)
   Yes                                                                             423                 (72.3)                        238                 (80.1)    185   (64.2)              56.3 (51.4--61.1)
  Liver disease                                                                                                                                                                              
   No                                                                              525                 (89.7)    0                   260                 (87.5)    265   (92.0)    0.08      49.5 (45.2--53.9)
   Yes                                                                             60                  (10.3)                        37                  (12.5)    23    (8.0)               61.7 (48.2--73.9)
  Vascular disease                                                                                                                                                                           
   No                                                                              422                 (72.1)    0                   184                 (62.0)    238   (82.6)    \<0.001   43.6 (38.8--48.5)
   Yes                                                                             163                 (27.9)                        113                 (38.0)    50    (17.4)              69.3 (61.6--76.3)
  **Substance use**                                                                                                                                                                          
  Alcohol use disorder                                                                                                                                                                       
   No                                                                              537                 (91.8)    0                   269                 (90.6)    268   (93.1)    0.29      50.1 (45.8--54.4)
   Yes                                                                             48                  (8.2)                         28                  (9.4)     20    (6.9)               58.3 (43.2--72.4)
  Smoking                                                                                                                                                                                    
   Never                                                                           216                 (36.9)    31                  106                 (35.7)    110   (38.2)    0.30      49.1 (42.2--55.9)
   Former                                                                          179                 (30.6)                        89                  (30.0)    90    (31.3)              49.7 (42.2--57.3)
   Current                                                                         159                 (27.2)                        90                  (30.3)    69    (24.0)              56.6 (48.5--64.4)
  **Medication history in year prior to test date**                                                                                                                                          
  Any angiotensin converting enzyme inhibitor or angiotensin II receptor blocker                                                                                                             
   No                                                                              330                 (56.4)    0                   150                 (50.5)    180   (62.5)    0.004     45.5 (40.0--51.0)
   Yes                                                                             255                 (43.6)                        147                 (49.5)    108   (37.5)              57.7 (51.3--63.8)
  Angiotensin converting enzyme inhibitor                                                                                                                                                    
   No                                                                              416                 (71.1)    0                   194                 (65.3)    222   (77.1)    0.002     46.6 (41.8--51.6)
   Yes                                                                             169                 (28.9)                        103                 (34.7)    66    (22.9)              61.0 (53.2--68.4)
  Angiotensin II receptor blocker                                                                                                                                                            
   No                                                                              491                 (83.9)    0                   248                 (83.5)    243   (84.4)    0.82      50.5 (46.0--55.0)
   Yes                                                                             94                  (16.1)                        49                  (16.5)    45    (15.6)              52.1 (41.6--62.5)
  Chemotherapy or immunsuppresive drug                                                                                                                                                       
   No                                                                              556                 (95.0)    0                   279                 (93.9)    277   (96.2)    0.25      50.2 (45.9--54.4)
   Yes                                                                             29                  (5.0)                         18                  (6.1)     11    (3.8)               62.1 (42.3--79.3)
  Nonsteroidal anti-inflammatory drug, (−365, −14 days)                                                                                                                                      
   No                                                                              392                 (67.0)    0                   207                 (69.7)    185   (64.2)    0.19      52.8 (47.7--57.8)
   Yes                                                                             193                 (33.0)                        90                  (30.3)    103   (35.8)              46.6 (39.4--53.9)
  **Vital signs at test date**                                                                                                                                                               
  Body mass index, kg/m^2^                                                                                                                                                                   
   \<25.0                                                                          73                  (12.5)    55                  45                  (15.2)    28    (9.7)     0.25      61.6 (49.5--72.8)
   25.0--29.9                                                                      166                 (28.4)                        85                  (28.6)    81    (28.1)              51.2 (43.3--59.0)
   ≥30                                                                             291                 (49.7)                        149                 (50.2)    142   (49.3)              51.2 (45.3--57.1)
  Hypoxia (oxygen saturation ≤93%)                                                                                                                                                           
   No                                                                              443                 (75.7)    64                  226                 (76.1)    217   (75.3)    \<0.001   51.0 (46.3--55.8)
   Yes                                                                             78                  (13.3)                        58                  (19.5)    20    (6.9)               74.4 (63.2--83.6)
  Pulse ≥90 beats per minute                                                                                                                                                                 
   No                                                                              295                 (50.4)    33                  150                 (50.5)    145   (50.3)    0.20      50.9 (45.0--56.7)
   Yes                                                                             257                 (43.9)                        145                 (48.8)    112   (38.9)              56.4 (50.1--62.6)
  Systolic blood pressure, mm Hg                                                                                                                                                             
   \<90                                                                            63                  (10.8)    37                  43                  (14.5)    20    (6.9)     0.04      68.3 (55.3--79.4)
   90--140                                                                         274                 (46.8)                        145                 (48.8)    129   (44.8)              52.9 (46.8--59.0)
   ≥140                                                                            211                 (36.1)                        106                 (35.7)    105   (36.5)              50.2 (43.3--57.2)
  Temperature, °F                                                                                                                                                                            
   \<98.6                                                                          204                 (34.9)    34                  88                  (29.6)    116   (40.3)    0.002     43.1 (36.2--50.2)
   98.7--100.3                                                                     227                 (38.8)                        134                 (45.1)    93    (32.3)              59.0 (52.3--65.5)
   ≥100.4                                                                          120                 (20.5)                        70                  (23.6)    50    (17.4)              58.3 (49.0--67.3)
  **Laboratory findings at test date**                                                                                                                                                       
  Alanine aminotransferase, U/L                                                                                                                                                              
   Median (IQR)                                                                    28.0 (19.0--41.0)   41        30.0 (20.0--42.0)   26.0 (18.0--37.0)   0.01                                
   ≤40                                                                             406                 (69.4)                        205                 (69.0)    201   (69.8)    0.01      50.5 (45.5--55.5)
   \>40                                                                            138                 (23.6)                        87                  (29.3)    51    (17.7)              63.0 (54.4--71.1)
  Albumin, g/dL                                                                                                                                                                              
  Median (IQR)                                                                     3.8 (3.5--4.2)      41        3.7 (3.3--4.0)      4.1 (3.7--4.3)      \<0.001                             
   ≥3.5                                                                            415                 (70.9)                        191                 (64.3)    224   (77.8)    \<0.001   46.0 (41.2--51.0)
   \<3.5                                                                           129                 (22.1)                        103                 (34.7)    26    (9.0)               79.8 (71.9--86.4)
  Aspartate aminotransferase, U/L                                                                                                                                                            
  Median (IQR)                                                                     29.0 (21.5--43.0)   37        35.5 (25.0--54.0)   25.0 (20.0--33.0)   \<0.001                             
   ≤40                                                                             391                 (66.8)                        173                 (58.2)    218   (75.7)    \<0.001   44.3 (39.3--49.3)
   \>40                                                                            157                 (26.8)                        121                 (40.7)    36    (12.5)              77.1 (69.7--83.4)
  Creatinine, mg/dL                                                                                                                                                                          
  Median (IQR)                                                                     1.1 (1.0--1.5)      20        1.3 (1.0--1.8)      1.1 (0.9--1.3)      \<0.001                             
   ≤1.5                                                                            435                 (74.4)                        200                 (67.3)    235   (81.6)    \<0.001   46.0 (41.2--50.8)
   \>1.5                                                                           130                 (22.2)                        97                  (32.7)    33    (11.5)              74.6 (66.2--81.8)
  eGFR, mL/min                                                                                                                                                                               
  Median (IQR)                                                                     71.5 (53.0--87.0)   17        63.0 (42.0--82.0)   75.0 (64.0--93.0)   \<0.001                             
   ≥15                                                                             541                 (92.5)                        277                 (93.3)    264   (91.7)    0.03      51.2 (46.9--55.5)
   \<15                                                                            27                  (4.6)                         20                  (6.7)     7     (2.4)               74.1 (53.7--88.9)
  FIB-4                                                                                                                                                                                      
   \<1.45                                                                          139                 (23.8)    69                  36                  (12.1)    103   (35.8)    \<0.001   25.9 (18.9--34.0)
   1.45--3.25                                                                      263                 (45.0)                        153                 (51.5)    110   (38.2)              58.2 (52.0--64.2)
   \>3.25                                                                          114                 (19.5)                        94                  (31.6)    20    (6.9)               82.5 (74.2--88.9)
  Hemoglobin, g/dL                                                                                                                                                                           
   Median (IQR)                                                                    13.9 (12.6--14.9)   45        13.6 (12.0--14.7)   14.2 (13.2--15.1)   \<0.001                             
   ≥10                                                                             523                 (89.4)                        273                 (91.9)    250   (86.8)    0.02      52.2 (47.8--56.6)
   \<10                                                                            17                  (2.9)                         14                  (4.7)     3     (1.0)               82.4 (56.6--96.2)
  Platelet count, K/μL                                                                                                                                                                       
   Median (IQR)                                                                    193 (154--230)      48        175 (143--216)      208 (173--252)      \<0.001                             
   ≥150                                                                            416                 (71.1)                        200                 (67.3)    216   (75.0)    \<0.001   48.1 (43.2--53.0)
   \<150                                                                           121                 (20.7)                        88                  (29.6)    33    (11.5)              72.7 (63.9--80.4)
  White blood cell count, K/μL                                                                                                                                                               
  Median (IQR)                                                                     5.9 (4.7--7.5)      32        5.9 (4.6--7.7)      5.9 (4.7--7.3)      0.54                                
   \<4                                                                             72                  (12.3)                        42                  (14.1)    30    (10.4)    0.005     58.3 (46.1--69.9)
   4--9.9                                                                          432                 (73.8)                        217                 (73.1)    215   (74.7)              50.2 (45.4--55.1)
   ≥10                                                                             49                  (8.4)                         36                  (12.1)    13    (4.5)               73.5 (58.9--85.1)
  Lymphocyte count, K/μL                                                                                                                                                                     
   Median (IQR)                                                                    1.1 (0.8--1.6)      92        0.9 (0.6--1.3)      1.4 (1.0--1.9)      \<0.001                             
   ≥0.8                                                                            363                 (62.1)                        179                 (60.3)    184   (63.9)    \<0.001   49.3 (44.1--54.6)
   \<0.8                                                                           130                 (22.2)                        105                 (35.4)    25    (8.7)               80.8 (72.9--87.2)
  VACS Index score^[b](#TFN7){ref-type="table-fn"}^, median (IQR)                  72.4 (63.6--82.5)   51        78.7 (71.1--87.3)   66.2 (60.0--73.2)   \<0.001                             

Abbreviations: Covid-19, coronavirus disease 2019; IQR, interquartile range; eGFR, estimated glomerular filtration rate, FIB-4, fibrosis 4 score; VACS, Veterans Aging Cohort Study

P-values calculated on non-missing data

TheVACS Index score is a validated measure of physiologic injury and combining age, aspartate and alanine transaminase, albumin, creatinine, hemoglobin, platelets, white blood cell count, hepatitis C status, and body mass index

###### 

Associations with intensive care among Covid-19 cases aged 54--75 years in the Veterans Health Administration as of March 30,2020

                                                                                                                                     Intensive care                                          
  -------------------------------------------------------------------------------- ------------------- --------- ------------------- ------------------- --------- ----- --------- --------- -------------------
  n                                                                                585                 \(100\)                       122                 (100.0)   463   (100.0)             20.9 (17.6--24.4)
  **Demographics**                                                                                                                                                                           
  Age, years                                                                                                                                                                                 
   Median (IQR)                                                                    66.1 (60.4--71.0)   0         69.9 (64.4--71.7)   64.7 (59.8--70.8)   \<0.001                             
   54--59                                                                          135                 (23.1)                        11                  (9.0)     124   (26.8)    \<0.001   8.2 (4.1--14.1)
   60--64                                                                          135                 (23.1)                        24                  (19.7)    111   (24.0)              17.8 (11.7--25.3)
   65--69                                                                          120                 (20.5)                        28                  (23.0)    92    (19.9)              23.3 (16.1--31.9)
   70--75                                                                          195                 (33.3)                        59                  (48.4)    136   (29.4)              30.3 (23.9--37.2)
  Sex                                                                                                                                                                                        
   Female                                                                          27                  (4.6)     0                   3                   (2.5)     24    (5.2)     0.33      11.1 (2.4--29.2)
   Male                                                                            558                 (95.4)                        119                 (97.5)    439   (94.8)              21.3 (18.0--25.0)
  Race/ethnicity                                                                                                                                                                             
   White                                                                           161                 (27.5)    0                   37                  (30.3)    124   (26.8)    0.89      23.0 (16.7--30.3)
   Black                                                                           350                 (59.8)                        71                  (58.2)    279   (60.3)              20.3 (16.2--24.9)
   Latinx                                                                          48                  (8.2)                         9                   (7.4)     39    (8.4)               18.8 (9.0--32.6)
   Other/unknown                                                                   26                  (4.4)                         5                   (4.1)     21    (4.5)               19.2 (6.6--39.4)
  Residence type                                                                                                                                                                             
   Rural                                                                           56                  (9.6)     0                   9                   (7.4)     47    (10.2)    0.49      16.1 (7.6--28.3)
   Urban                                                                           529                 (90.4)                        113                 (92.6)    416   (89.8)              21.4 (17.9--25.1)
  **Baseline comorbidity**                                                                                                                                                                   
  Asthma                                                                                                                                                                                     
   No                                                                              540                 (92.3)    0                   111                 (91.0)    429   (92.7)    0.57      20.6 (17.2--24.2)
   Yes                                                                             45                  (7.7)                         11                  (9.0)     34    (7.3)               24.4 (12.9--39.5)
  Cancer                                                                                                                                                                                     
   No                                                                              502                 (85.8)    0                   104                 (85.2)    398   (86.0)    0.88      20.7 (17.3--24.5)
   Yes                                                                             83                  (14.2)                        18                  (14.8)    65    (14.0)              21.7 (13.4--32.1)
  Chronic kidney disease                                                                                                                                                                     
   No                                                                              474                 (81.0)    0                   90                  (73.8)    384   (82.9)    0.03      19.0 (15.6--22.8)
   Yes                                                                             111                 (19.0)                        32                  (26.2)    79    (17.1)              28.8 (20.6--38.2)
  Chronic obstructive pulmonary disease                                                                                                                                                      
   No                                                                              495                 (84.6)    0                   94                  (77.0)    401   (86.6)    0.02      19.0 (15.6--22.7)
   Yes                                                                             90                  (15.4)                        28                  (23.0)    62    (13.4)              31.1 (21.8--41.7)
  Diabetes mellitus                                                                                                                                                                          
   No                                                                              325                 (55.6)    0                   49                  (40.2)    276   (59.6)    \<0.001   15.1 (11.4--19.4)
   Yes                                                                             260                 (44.4)                        73                  (59.8)    187   (40.4)              28.1 (22.7--34.0)
  Hypertension                                                                                                                                                                               
   No                                                                              162                 (27.7)    0                   17                  (13.9)    145   (31.3)    \<0.001   10.5 (6.2--16.3)
   Yes                                                                             423                 (72.3)                        105                 (86.1)    318   (68.7)              24.8 (20.8--29.2)
  Liver disease                                                                                                                                                                              
   No                                                                              525                 (89.7)    0                   107                 (87.7)    418   (90.3)    0.40      20.4 (17.0--24.1)
   Yes                                                                             60                  (10.3)                        15                  (12.3)    45    (9.7)               25.0 (14.7--37.9)
  Vascular disease                                                                                                                                                                           
   No                                                                              422                 (72.1)    0                   74                  (60.7)    348   (75.2)    0.002     17.5 (14.0--21.5)
   Yes                                                                             163                 (27.9)                        48                  (39.3)    115   (24.8)              29.5 (22.6--37.1)
  **Substance use**                                                                                                                                                                          
  Alcohol use disorder                                                                                                                                                                       
   No                                                                              537                 (91.8)    0                   115                 (94.3)    422   (91.1)    0.35      21.4 (18.0--25.1)
   Yes                                                                             48                  (8.2)                         7                   (5.7)     41    (8.9)               14.6 (6.1--27.8)
  Smoking                                                                                                                                                                                    
   Never                                                                           216                 (36.9)    31                  43                  (35.2)    173   (37.4)    0.60      19.9 (14.8--25.9)
   Former                                                                          179                 (30.6)                        36                  (29.5)    143   (30.9)              20.1 (14.5--26.7)
   Current                                                                         159                 (27.2)                        38                  (23.9)    121   (26.1)              23.9 (17.5--31.3)
  **Medication history in year prior to test date**                                                                                                                                          
  Any angiotensin converting enzyme inhibitor or angiotensin II receptor blocker                                                                                                             
   No                                                                              330                 (56.4)    0                   53                  (43.4)    277   (59.8)    0.001     16.1 (12.3--20.5)
   Yes                                                                             255                 (43.6)                        69                  (56.6)    186   (40.2)              27.1 (21.7--33.0)
  Angiotensin converting enzyme inhibitor                                                                                                                                                    
   No                                                                              416                 (71.1)    0                   72                  (59.0)    344   (74.3)    0.002     17.3 (13.8--21.3)
   Yes                                                                             169                 (28.9)                        50                  (41.0)    119   (25.7)              29.6 (22.8--37.1)
  Angiotensin II receptor blocker                                                                                                                                                            
   No                                                                              491                 (83.9)    0                   99                  (81.1)    392   (84.7)    0.34      20.2 (16.7--24.0)
   Yes                                                                             94                  (16.1)                        23                  (18.9)    71    (15.3)              24.5 (16.2--34.4)
  Chemotherapy or immunsuppresive drug                                                                                                                                                       
   No                                                                              556                 (95.0)    0                   115                 (94.3)    441   (95.2)    0.64      20.7 (17.4--24.3)
   Yes                                                                             29                  (5.0)                         7                   (5.7)     22    (4.8)               24.1 (10.3--43.5)
  Nonsteroidal anti-inflammatory drug, (−365, −14 days)                                                                                                                                      
   No                                                                              392                 (67.0)    0                   90                  (73.8)    302   (65.2)    0.08      23.0 (18.9--27.5)
   Yes                                                                             193                 (33.0)                        32                  (26.2)    161   (34.8)              16.6 (11.6--22.6)
  **Vital signs at test date**                                                                                                                                                               
  Body mass index, kg/m^2^                                                                                                                                                                   
   \<25.0                                                                          73                  (12.5)    55                  19                  (15.6)    54    (11.7)    0.18      26.0 (16.5--37.6)
   25.0--29.9                                                                      166                 (28.4)                        28                  (23.0)    138   (29.8)              16.9 (11.5--23.5)
   ≥30                                                                             291                 (49.7)                        67                  (23.0)    224   (48.4)              23.0 (18.3--28.3)
  Hypoxia (oxygen saturation \<93%)                                                                                                                                                          
   No                                                                              443                 (75.7)    64                  87                  (71.3)    356   (76.9)    \<0.001   19.6 (16.0--23.7)
   Yes                                                                             78                  (13.3)                        30                  (24.6)    48    (10.4)              38.5 (27.7--50.2)
  Pulse ≥90 beats per minute                                                                                                                                                                 
   No                                                                              295                 (50.4)    33                  53                  (43.4)    242   (52.3)    0.02      18.0 (13.8--22.8)
   Yes                                                                             257                 (43.9)                        68                  (55.7)    189   (40.8)              26.5 (21.2--32.3)
  Systolic blood pressure, mm Hg                                                                                                                                                             
   \<90                                                                            63                  (10.8)    37                  17                  (13.9)    46    (9.9)     0.57      27.0 (16.6--39.7)
   90--140                                                                         274                 (46.8)                        60                  (49.2)    214   (46.2)              21.9 (17.2--27.3)
   ≥140                                                                            211                 (36.1)                        44                  (36.1)    167   (36.1)              20.9 (15.6--27.0)
  Temperature, °F                                                                                                                                                                            
   ≤98.6                                                                           204                 (34.9)    34                  28                  (23.0)    176   (38.0)    0.002     13.7 (9.3--19.2)
   98.7--100.3                                                                     227                 (38.8)                        56                  (45.9)    171   (36.9)              24.7 (19.2--30.8)
   ≥100.4                                                                          120                 (20.5)                        34                  (27.9)    86    (18.6)              28.3 (20.5--37.3)
  **Laboratory findings at test date**                                                                                                                                                       
  Alanine aminotransferase, U/L                                                                                                                                                              
   Median (IQR)                                                                    28.0(19.0--41.0)    41        32.0(21.0--47.0)    27.0(19.0--38.0)    0.02                                
   ≤40                                                                             406                 (69.4)                        78                  (63.9)    328   (70.8)    0.004     19.2 (15.5--23.4)
   \>40                                                                            138                 (23.6)                        43                  (35.2)    95    (20.5)              31.2 (23.6--39.6)
  Albumin, g/dL                                                                                                                                                                              
   Median (IQR)                                                                    3.8 (3.5--4.2)      41        3.6 (3.2--3.9)      3.9 (3.6--4.2)      \<0.001                             
   ≥3.5                                                                            415                 (70.9)                        68                  (55.7)    347   (74.9)    \<0.001   16.4 (13.0--20.3)
   \<3.5                                                                           129                 (22.1)                        54                  (44.3)    75    (16.2)              41.9 (33.2--50.9)
  Aspartate aminotransferase, U/L                                                                                                                                                            
   Median (IQR)                                                                    29.0(21.5--43.0)    37        42.0(27.0--68.0)    27.0(21.0--39.0)    \<0.001                             
   ≤40                                                                             391                 (66.8)                        59                  (48.4)    332   (71.7)    \<0.001   15.1 (11.7--19.0)
   \>40                                                                            157                 (26.8)                        63                  (51.6)    94    (20.3)              40.1 (32.4--48.2)
  Creatinine, mg/dL                                                                                                                                                                          
  Median (IQR)                                                                     1.1 (1.0--1.5)      20        1.4(1.1--2.0)       1.1 (0.9--1.4)      \<0.001                             
   ≤1.5                                                                            435                 (74.4)                        72                  (59.0)    363   (78.4)    \<0.001   16.6 (13.2--20.4)
   \>1.5                                                                           130                 (22.2)                        50                  (41.0)    80    (17.3)              38.5 (30.1--47.4)
  eGFR, mL/min                                                                                                                                                                               
   Median (IQR)                                                                    71.5 (53.0--87.0)   17        55.5 (37.0--76.0)   74.0(58.0--90.0)    \<0.001                             
   ≥15                                                                             541                 (92.5)                        110                 (90.2)    431   (93.1)    0.006     20.3 (17.0--24.0)
   \<15                                                                            27                  (4.6)                         12                  (9.8)     15    (3.2)               44.4 (25.5--64.7)
  FIB-4                                                                                                                                                                                      
   \<1.45                                                                          139                 (23.8)    69                  6                   (4.9)     133   (28.7)    \<0.001   4.3 (1.6--9.2)
   1.45--3.25                                                                      263                 (45.0)                        66                  (54.1)    197   (42.5)              25.1 (20.0--30.8)
   \>3.25                                                                          114                 (19.5)                        44                  (36.1)    70    (15.1)              38.6 (29.6--48.2)
  Hemoglobin, g/dL                                                                                                                                                                           
   Median (IQR)                                                                    13.9(12.6--14.9)    45        13.6(11.9--14.7)    14.0(12.8--15.0)    0.02                                
   ≥10                                                                             523                 (89.4)                        109                 (89.3)    414   (89.4)    0.02      20.8 (17.4--24.6)
   \<10                                                                            17                  (2.9)                         8                   (6.6)     9     (1.9)               47.1 (23.0--72.2)
  Platelet count, K/μL                                                                                                                                                                       
   Median (IQR)                                                                    193 (154--230)      48        175 (144--228)      195 (157--231)      0.05                                
   ≥150                                                                            416                 (71.1)                        82                  (19.7)    334   (72.1)    0.03      19.7 (16.0--23.9)
   \<150                                                                           121                 (20.7)                        35                  (28.9)    86    (18.6)              28.9 (21.1--37.9)
  White blood cell count, K/μL                                                                                                                                                               
  Median (IQR)                                                                     5.9 (4.7--7.5)      32        6.2 (5.2--8.9)      5.7 (4.6--7.2)      \<0.001                             
   \<4                                                                             72                  (12.3)                        12                  (16.7)    60    (13.0)    0.002     16.7 (8.9--27.3)
   4--9.9                                                                          432                 (73.8)                        89                  (20.6)    343   (74.1)              20.6 (16.9--24.7)
   ≥10                                                                             49                  (8.4)                         21                  (42.9)    28    (6.0)               42.9 (28.8--57.8)
  Lymphocyte count, K/μL                                                                                                                                                                     
   Median (IQR)                                                                    1.1 (0.8--1.6)      92        0.8 (0.6--1.1)      1.2 (0.8--1.8)      \<0.001                             
   ≥0.8                                                                            363                 (62.1)                        71                  (19.6)    292   (63.1)    \<0.001   19.6 (15.6--24.0)
   \<0.8                                                                           130                 (22.2)                        48                  (36.9)    82    (17.7)              36.9 (28.6--45.8)
  VACS Index score^[b](#TFN10){ref-type="table-fn"}^, median (IQR)                 72.4 (63.6--82.5)   51        82.0 (74.0--91.1)   69.4 (61.1--79.1)   \<0.001                             

Abbreviations: Covid-19, coronavirus disease 2019; IQR, interquartile range; eGFR, estimated glomerular filtration rate, FIB-4, fibrosis 4 score; VACS, Veterans Aging Cohort Study

P-values calculated on non-missing data

TheVACS Index score is a validated measure of physiologic injury and combining age, aspartate and alanine transaminase, albumin, creatinine, hemoglobin, platelets, white blood cell count, hepatitis C status, and body mass index

###### 

Crude and adjusted associations with hospitalization and intensive care among Covid-19 cases as of March 30, 2020

                                                                                           Hospitalization (n=297/585)   Intensive care (n=122/585)                                                                  
  ---------------------------------------------------------------------------------------- ----------------------------- ---------------------------- ------------------- --------------------- -------------------- -------------------
  **Model details**                                                                                                                                                                                                  
  C-statistic                                                                              \-                            0.859                        0.834               \-                    0.876                0.835
  **Demographics**                                                                                                                                                                                                   
  Age, per 5-year increase                                                                 1.26 (1.10--1.44)             0.87 (0.71--1.05)            0.64 (0.51--0.80)   1.55 (1.30--1.86)     1.31 (1.03--1.66)    0.98 (0.76--1.26)
  Race/ethnicity, black vs. other                                                          1.30 (0.94--1.82)             0.96 (0.61--1.53)            1.14 (0.74--1.74)   0.92 (0.61--1.38)     0.94 (0.55--1.63)    0.98 (0.60--1.61)
  **Baseline comorbidity**                                                                                                                                                                                           
  Chronic kidney disease, yes vs. no                                                       2.36 (1.53--3.66)             0.80 (0.41--1.56)            0.84 (0.47--1.49)   1.73 (1.08--2.77)     0.50 (0.24--1.06)    0.65 (0.35--1.21)
  Chronic obstructive pulmonary disease, yes vs. no                                        2.31 (1.43--3.72)             1.77 (0.92--3.41)            1.15 (0.62--2.12)   1.93 (1.17--3.18)     1.81 (0.92--3.58)    1.47 (0.79--2.73)
  Diabetes mellitus, yes vs. no                                                            1.96 (1.41--2.73)             1.59 (1.00--2.53)            1.36 (0.89--2.09)   2.20 (1.46--3.30)     1.69 (0.96--2.98)    1.41 (0.85--2.35)
  Hypertension, yes vs.no                                                                  2.25 (1.55--3.26)             1.39 (0.78--2.46)            1.50 (0.88--2.54)   2.81 (1.63--4.88)     1.51 (0.70--3.28)    1.89 (0.93--3.87)
  Vascular disease, yes vs. no                                                             2.92 (1.99--4.29)             1.58 (0.93--2.69)            1.58 (0.96--2.60)   1.96 (1.29--2.99)     0.73 (0.40--1.33)    0.77 (0.44--1.34)
  **Medication history in year prior to test date**                                                                                                                                                                  
  Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, yes vs. no   1.63 (1.17--2.27)             1.15 (0.71--1.87)            1.24 (0.79--1.95)   1.94 (1.30--2.90)     1.66 (0.94--2.93)    1.69 (1.01--2.84)
  Nonsteroidal anti-inflammatory drug, yes vs. no                                          0.78 (0.55--1.10)             1.18 (0.74--1.89)            1.09 (0.71--1.67)   0.67 (0.43--1.04)     1.16 (0.65--2.06)    0.98 (0.57--1.67)
  **Vital signs**                                                                                                                                                                                                    
  Systolic blood pressure, per 5 mm Hg decrease                                            1.10 (1.03--1.17)             1.08 (1.00--1.18)            1.09 (1.00--1.17)   1.05 (0.98--1.13)     1.00 (0.92--1.10)    1.00 (0.91--1.09)
  Oxygen saturation, per 1% decrease                                                       1.14 (1.06--1.23)             1.04 (0.95--1.14)            1.12 (1.02--1.22)   1.16 (1.09--1.24)     1.05 (0.97--1.14)    1.13 (1.05--1.21)
  Pulse, per 5-beats per minute increase                                                   0.97 (0.95--0.99)             0.97 (0.95--099)             0.97 (0.95--0.99)   0.99 (0.97--1.00)     1.00 (0.97--1.02)    0.99 (0.97--1.01)
  Temperature, per 1°F increase                                                            1.20 (1.07--1.36)             1.15 (0.98--1.34)            1.24 (1.08--1.44)   1.28 (1.12--1.47)     1.32 (1.10--1.58)    1.37 (1.16--1.61)
  **Laboratory findings**                                                                                                                                                                                            
  Albumin, per 1 g/dL decrease                                                             10.43 (5.70--19.08)           3.75 (1.91--7.35)            \-                  6.17 (3.62--10.52)    3.34 (1.70--6.54)    \-
  eGFR, per 10 mL/min decrease FIB-4                                                       1.29 (1.19--1.40)             1.18 (1.05--1.32)            \-                  1.31 (1.21--1.43)     1.29 (1.15--1.46)    \-
   \<1.45                                                                                  ref                           ref                          \-                  ref                   ref                  \-
   1.45--3.25                                                                              3.92 (2.53--6.08)             2.96 (1.69--5.17)            \-                  6.31 (2.74--14.50)    4.59 (1.72--12.22)   \-
   \>3.25                                                                                  12.37 (6.73--22.72)           8.73 (4.11--18.56)           \-                  12.43 (5.24--29.50)   8.40 (2.90--24.28)   \-
  Hemoglobin, per 1 g/dL decrease                                                          1.55 (1.32--1.83)             1.16 (0.93--1.43)            \-                  1.33 (1.14, 1.54)     1.00 (0.81--1.23)    \-
  White blood cell count, per 1 K/μL increase                                              1.05 (0.96--1.15)             1.24 (1.08--1.43)            \-                  1.22 (1.10--1.36)     1.49 (1.27--1.73)    \-
  Lymphocyte count, per 1 K/μL decrease                                                    2.68 (2.00--3.60)             2.38 (1.68--3.39)            \-                  2.76 (1.87--4.09)     2.65 (1.68--4.18)    \-
  VACS Index score^[a](#TFN12){ref-type="table-fn"}^, per 5-point increase                 1.48 (1.36--1.61)             \-                           1.62 (1.43--1.84)   1.45 (1.33--1.58)     \-                   1.47 (1.31--1.65)

Abbreviations: Covid-19, coronavirus disease 2019; OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate, FIB-4, fibrosis 4 score; VACS, Veterans Aging Cohort Study

The VACS Index score is a validated measure of physiologic injury combining age, aspartate and alanine transaminase, albumin, creatinine, hemoglobin, platelets, white blood cell count, hepatitis C status, and body mass index

###### Key Points

Question: {#S25}
=========

What are the demographic and clinical characteristics associated with testing positive for coronavirus 2019 (Covid-19+), and among Covid-19+ subsequent hospitalization and intensive care among Veterans in the United States?

Findings: {#S26}
=========

In this retrospective cohort study of 2,026,227 Veterans aged 54--75 years and active in care, 585/3,789 (15.4%) tested Covid-19+. Black race was strongly associated with Covid-19+, but not with hospitalization or intensive care. Among Covid-19+, laboratory abnormalities and a summary measure of physiologic injury were strongly associated with hospitalization and intensive care.

Meaning: {#S27}
========

Racial differences in testing positive for Covid-19 may be an underestimate of the general population as racial health disparities in the Veterans Affairs Healthcare System tend to be smaller than in the private sector. Risk of hospitalization and intensive care may be better characterized by laboratory measures and vital signs than by comorbid conditions or prior medication exposure.
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